Characteristics and treatment patterns of older ms patients treated with peginterferon beta-1a or intramuscular interferon beta-1a in the real world

被引：0
|
作者：
Vignos, M. [1 ]
Altincatal, A. [1 ]
Mendoza, J. [1 ]
Avila, R. [1 ]
Makin, C. [1 ]
机构：
[1] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0844
引用
收藏
页码：520 / 520
页数：1
相关论文
共 50 条
  • [21] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [22] Peginterferon Beta-1a (Plegridy) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1468): : 1 - 3
  • [23] Infections in alemtuzumab patients previously treated with subcutaneous interferon beta-1a
    Lycke, J.
    Cohen, J. A.
    Fox, E. J.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K. W.
    Margolin, D. H.
    Kasten, L.
    Compston, D. A. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 658 - 658
  • [24] Pregnancy Outcomes in Patients Exposed to Intramuscular Interferon beta-1a (IM IFNβ-1a)
    Tomczyk, Sylvie
    Sperling, Bjorn
    NEUROLOGY, 2013, 80
  • [25] Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a
    Rudick, R. A.
    Pace, A.
    Rani, M. R. S.
    Hyde, R.
    Panzara, M.
    Appachi, S.
    Shrock, J.
    Maurer, S. L.
    Calabresi, P. A.
    Confavreux, C.
    Galetta, S. L.
    Lublin, F. D.
    Radue, E. -W.
    Ransohoff, R. M.
    NEUROLOGY, 2009, 72 (23) : 1989 - 1993
  • [26] Interferon beta-1a treatment and African Americans - In reply
    Cree, BAC
    ARCHIVES OF NEUROLOGY, 2006, 63 (04) : 628 - 628
  • [27] Early treatment with interferon beta-1a slows onset of clinically definite MS
    不详
    FORMULARY, 2000, 35 (12) : 952 - +
  • [28] COMPARE: a phase 1 pharmacokinetic study of subcutaneous peginterferon beta-1a vs subcutaneous interferon beta-1a over 2 weeks in healthy subjects
    Hu, X.
    Shang, S.
    Nestorov, I.
    Dawson, K.
    Sperling, B.
    Werneburg, B.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 597 - 598
  • [29] Efficacy and Safety of Daclizumab Beta Vs Intramuscular Interferon Beta-1a in Patients Previously Treated with Glatiramer Acetate in the Decide Study
    Khatri, Bhupendra
    Cohan, Stanley
    Ziemssen, Tjalf
    Ford, Corey
    Arnold, Douglas L.
    Robinson, Randy R.
    Riester, Katherine
    Fam, Sami
    Giannattasio, Giorgio
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 30 - 30
  • [30] Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS
    Kümpfel, T
    Bergh, FT
    Pollmächer, T
    Holsboer, F
    Trenkwalder, C
    NEUROLOGY, 2000, 55 (08) : 1231 - 1233
12345